An AI-powered biomarker based on histology alone predicted survival among men with metastatic hormone-sensitive prostate cancer and identified those who benefitted from escalation to triplet therapy.

When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...

Localized prostate cancer treatments include radical prostatectomy and focal therapy, with the latter targeting only cancerous areas to preserve healthy tissue. Focal therapy allows for active ...

Prostate cancer relapse treatment could be cut from 35 visits to just five. See how new radiation technology may change your ...

Prostate cancer is common in men, with risk factors including age, family history, and genetic mutations. Early-stage cancer often lacks symptoms. Diagnosis involves PSA tests, digital rectal exams, ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

Lord David Cameron has revealed he was diagnosed with, and successfully treated for, prostate cancer in the past year. The former prime minister also declared his support for a targeted screening ...

Prostate enlargement is a common age-related condition affecting millions of men. Learn about its symptoms, risk factors, ...

Men diagnosed with high-risk localized prostate cancer now have trial-level evidence that adding the drug apalutamide to ...

As a cancer researcher who knows very well about the high incidence and decreased survival rates of prostate cancer in the Caribbean, I anguished over these words. Even though I study cancer in my day ...